Solvay Resultados de beneficios anteriores
Pasado controles de criterios 1/6
Solvay ha aumentado sus beneficios a una tasa media anual de 18.8%, mientras que los beneficios de la industria de Chemicals han experimentado un crecimiento de 17.1% anual. Los ingresos han ido disminuyendo a una tasa media de 11% al año. La rentabilidad financiera de Solvay es de 9.2%, y sus márgenes netos son de 2.3%.
Información clave
18.8%
Tasa de crecimiento de los beneficios
18.8%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 23.2% |
| Tasa de crecimiento de los ingresos | -11.0% |
| Rentabilidad financiera | 9.2% |
| Margen neto | 2.3% |
| Próxima actualización de resultados | 31 Jul 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Are Investors Undervaluing Solvay SA (EBR:SOLB) By 37%?
Jun 14
Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
May 29Solvay SA (EBR:SOLB) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Apr 24Solvay SA's (EBR:SOLB) Business And Shares Still Trailing The Market
Mar 10Is Solvay SA (EBR:SOLB) Trading At A 28% Discount?
Nov 20Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.13
Nov 06The Return Trends At Solvay (EBR:SOLB) Look Promising
Nov 02Here's Why Solvay (EBR:SOLB) Can Manage Its Debt Responsibly
Oct 19Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
Aug 16Returns At Solvay (EBR:SOLB) Are On The Way Up
Aug 02Is Solvay (EBR:SOLB) A Risky Investment?
Jul 19An Intrinsic Calculation For Solvay SA (EBR:SOLB) Suggests It's 26% Undervalued
Jul 06Solvay's (EBR:SOLB) Dividend Will Be Increased To €1.76
May 11Is Solvay SA (EBR:SOLB) Potentially Undervalued?
May 09Solvay's (EBR:SOLB) Returns On Capital Are Heading Higher
Apr 25Here's Why Solvay (EBR:SOLB) Can Manage Its Debt Responsibly
Apr 09Is There An Opportunity With Solvay SA's (EBR:SOLB) 21% Undervaluation?
Mar 27Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.76
Feb 27Solvay (EBR:SOLB) Has Announced That It Will Be Increasing Its Dividend To €1.08
Jan 09The Return Trends At Solvay (EBR:SOLB) Look Promising
Jan 05Solvay's (EBR:SOLB) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 20Solvay (EBR:SOLB) Seems To Use Debt Quite Sensibly
Dec 18At €94.20, Is Solvay SA (EBR:SOLB) Worth Looking At Closely?
Dec 02Solvay's (EBR:SOLB) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 17Solvay SA (EBR:SOLB) Shares Could Be 34% Below Their Intrinsic Value Estimate
Sep 13New Forecasts: Here's What Analysts Think The Future Holds For Solvay SA (EBR:SOLB)
Aug 07Is Now An Opportune Moment To Examine Solvay SA (EBR:SOLB)?
Jul 28We Think Solvay (EBR:SOLB) Can Stay On Top Of Its Debt
Jul 10Solvay SA's (EBR:SOLB) Intrinsic Value Is Potentially 89% Above Its Share Price
May 03At €88.04, Is Solvay SA (EBR:SOLB) Worth Looking At Closely?
Apr 15Solvay (EBR:SOLB) Has A Pretty Healthy Balance Sheet
Mar 28Desglose de ingresos y gastos
Cómo gana y gasta dinero Solvay. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 24 | 5,570 | 127 | 510 | 45 |
| 31 Dec 23 | 6,024 | -37 | 552 | 47 |
| 30 Sep 23 | 4,051 | -244 | 322 | -24 |
| 30 Jun 23 | 5,428 | -13 | 360 | -14 |
| 31 Mar 23 | 6,038 | 495 | 377 | -23 |
| 31 Dec 22 | 7,979 | 889 | 565 | 46 |
| 30 Sep 22 | 15,442 | 1,859 | 1,384 | 350 |
| 30 Jun 22 | 13,895 | 1,659 | 1,342 | 324 |
| 31 Mar 22 | 12,523 | 1,176 | 1,274 | 310 |
| 31 Dec 21 | 11,434 | 943 | 1,233 | 325 |
| 30 Sep 21 | 10,575 | 648 | 1,208 | 316 |
| 30 Jun 21 | 9,982 | 608 | 1,188 | 314 |
| 31 Mar 21 | 9,631 | -1,168 | 1,172 | 316 |
| 31 Dec 20 | 9,714 | -1,125 | 1,212 | 300 |
| 30 Sep 20 | 10,006 | -1,216 | 1,224 | 309 |
| 30 Jun 20 | 10,514 | -1,872 | 1,256 | 315 |
| 31 Mar 20 | 11,055 | -134 | 1,320 | 322 |
| 31 Dec 19 | 11,227 | -118 | 1,331 | 323 |
| 30 Sep 19 | 11,347 | 111 | 1,355 | 316 |
| 30 Jun 19 | 11,409 | 764 | 1,378 | 315 |
| 31 Mar 19 | 11,349 | 767 | 1,392 | 306 |
| 31 Dec 18 | 11,299 | 676 | 1,379 | 297 |
| 30 Sep 18 | 11,187 | 775 | 1,399 | 298 |
| 30 Jun 18 | 10,987 | 748 | 1,397 | 288 |
| 31 Mar 18 | 10,953 | 730 | 1,413 | 288 |
| 31 Dec 17 | 10,984 | 820 | 1,437 | 290 |
| 30 Sep 17 | 10,851 | 771 | 1,416 | 283 |
| 30 Jun 17 | 10,694 | 765 | 1,409 | 285 |
| 31 Mar 17 | 10,057 | 717 | 1,359 | 279 |
| 31 Dec 16 | 10,044 | 539 | 1,363 | 284 |
| 30 Sep 16 | 9,168 | 317 | 1,320 | 277 |
| 30 Jun 16 | 9,512 | 248 | 1,315 | 276 |
| 31 Mar 16 | 10,146 | 220 | 1,337 | 281 |
| 31 Dec 15 | 10,083 | 355 | 1,296 | 271 |
| 30 Sep 15 | 11,068 | 325 | 1,321 | 270 |
| 30 Jun 15 | 10,929 | 311 | 1,297 | 265 |
| 31 Mar 15 | 10,793 | 376 | 1,254 | 257 |
| 31 Dec 14 | 10,629 | 326 | 1,225 | 247 |
| 30 Sep 14 | 10,425 | 317 | 1,193 | 238 |
| 30 Jun 14 | 10,222 | 298 | 1,182 | 237 |
| 31 Mar 14 | 10,086 | 182 | 1,166 | 240 |
| 31 Dec 13 | 10,150 | 164 | 1,189 | 238 |
| 30 Sep 13 | 10,331 | 348 | 1,175 | 243 |
| 30 Jun 13 | 10,598 | 395 | 1,140 | 244 |
Ingresos de calidad: SOLB tiene una única gran pérdida de €350.0M que afecta a sus resultados financieros de los últimos 12 meses de 31st March, 2024.
Margen de beneficios creciente: Los actuales márgenes de beneficio(2.3%) de SOLB son inferiores a los del año pasado (8.2%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de SOLB han crecido un 18.8% al año en los últimos 5 años.
Acelerando crecimiento: SOLB ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: SOLB tuvo un crecimiento negativo de los beneficios (-74.3%) durante el año pasado, lo que dificulta la comparación con la media de la industria Chemicals (-42.1%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de SOLB (9.2%) se considera baja.